Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax

被引：4
|
作者：
Candoni, Anna [1 ,3 ]
Callegari, Chiara [1 ]
Zannier, Maria Elena [1 ]
Fanin, Renato [1 ,2 ]
机构：
[1] Div Hematol & Stem Cell Transplantat, ASUFC, Udine, Italy
[2] Univ Udine, DAME, Udine, Italy
[3] Univ Hosp Udine Azienda Sanit Univ Friuli Cent, Clin Ematolog, Piazzale S Maria Misericordia,15, I-33100 Udine, Italy
来源：
BLOOD ADVANCES | 2022年 / 6卷 / 10期
关键词：
D O I：
10.1182/bloodadvances.2021006949
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3068 / 3071
页数：4
相关论文
共 50 条
  • [1] Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis
    Anand, Shuchi
    Montez-Rath, Maria E.
    Han, Jialin
    Garcia, Pablo
    Cadden, LinaCel
    Hunsader, Patti
    Kerschmann, Russell
    Beyer, Paul
    Dittrich, Mary
    Block, Geoffrey A.
    Boyd, Scott D.
    Parsonnet, Julie
    Chertow, Glenn M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 2435 - 2438
  • [2] Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents
    Othman, Tamer A.
    Mei, Matthew
    Zhang, Jianying
    Aldoss, Ibrahim
    Stein, Anthony
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E140 - E143
  • [3] Antibody response to COVID-19 vaccination in patients with lymphoma
    Kentaro Narita
    So Nakaji
    Rikako Tabata
    Toshiki Terao
    Ayumi Kuzume
    Takafumi Tsushima
    Daisuke Ikeda
    Ami Fukumoto
    Daisuke Miura
    Masami Takeuchi
    Masahiro Doi
    Yuka Umezawa
    Yoshihito Otsuka
    Hiroyuki Takamatsu
    Kosei Matsue
    International Journal of Hematology, 2022, 115 : 728 - 736
  • [4] Antibody response to COVID-19 vaccination in patients with lymphoma
    Narita, Kentaro
    Nakaji, So
    Tabata, Rikako
    Terao, Toshiki
    Kuzume, Ayumi
    Tsushima, Takafumi
    Ikeda, Daisuke
    Fukumoto, Ami
    Miura, Daisuke
    Takeuchi, Masami
    Doi, Masahiro
    Umezawa, Yuka
    Otsuka, Yoshihito
    Takamatsu, Hiroyuki
    Matsue, Kosei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (05) : 728 - 736
  • [5] Clinical outcomes of patients receiving venetoclax and hypomethylating agents for AML in academic and academic-community partnerships
    Pham, Natalie
    Lantz, Jeffrey
    Jones, Caroline
    Kundu, Debamita
    McCann, Nicholas
    El Chaer, Firas
    Reed, Daniel
    Keng, Michael Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Serologic response to mRNA COVID-19 vaccination in lymphoma patients
    Jurgens, Eric Matthew
    Ketas, Thomas Joseph
    Zhao, Zhen
    Joseph Satlin, Michael
    Small, Catherine Butkus
    Sukhu, Ashley
    Francomano, Erik
    Klasse, Per Johan
    Garcia, Arcania
    Nguyenduy, Emeline
    Bhavsar, Erica
    Formenti, Silvia
    Furman, Richard
    Moore, John Philip
    Leonard, John Paul
    Martin, Peter
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (11) : E410 - E413
  • [7] Response to mRNA COVID-19 vaccination in three XLA patients
    Squire, J. D.
    Joshi, A. Y.
    VACCINE, 2022, 40 (36) : 5299 - 5301
  • [8] Results of Treatment With Hypomethylating Agents Versus Hypomethylating Agents/Venetoclax in Patients With AML Single-Center Experience
    Patino, Ana Flavia
    Brulc, Erika
    Conca, Alberto Gimenez
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S289 - S289
  • [9] Antibody Response to COVID-19 Vaccination in Patients with Lung Cancer
    Walter, J.
    Bolt, T.
    Elsner, L.
    Sellmer, L.
    Kahnert, K.
    Mertsch, P.
    Lehnert, N.
    Kauffmann-Guerrero, D.
    Behr, J.
    Tufman, A.
    PNEUMOLOGIE, 2023, 77 : S48 - S48
  • [10] Molecular stratification of response and survival of venetoclax in combination with hypomethylating agents in AML.
    Maher, Keri Renee
    Bouligny, Ian Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345